London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024
LONDON, Ontario, June 10, 2024 (GLOBE NEWSWIRE) — London Research & Pharmaceuticals presented notable pre-clinical data about its lead compound,…